Ryanair appoints Emer Daly to its Board of Directors alongside Kyran McLaughlin as Senior Independent Director

– IRELAND, Dublin – The Board of Ryanair Holdings Plc (LSE:RYA), today announced that Ms Emer Daly who is currently Board Chairman at RSA Insurance Ireland DAC, is a Non-Executive Director and Chair of the Audit Committee of Permanent TSB Group Holdings plc and of Chetwood Financial Limited, and who previously served as a Director of Payzone Plc and held senior roles with PricewaterhouseCoopers and AXA Insurance for over 20 years, has today joined the Board of Ryanair as a Non-Executive Director and a member of the Audit Committee.

Ryanair also announced the appointment today of Mr Kyran McLaughlin as Senior Independent Director of Ryanair Holdings Plc. Kyran has served as a non-executive director of Ryanair since Jan 2001, and is Deputy Chairman and Head of Capital Markets at Davy Stockbrokers.

Ryanair’s Chairman David Bonderman said: “We are pleased to welcome Emer Daly to the Board of Ryanair. Given Emer’s vast experience and skills in accounting and risk management she will, I believe, be a significant and valuable addition to our Board and its Audit Committee. Emer has joined the Board, and she will put herself forward for approval by shareholders at our AGM in September 2018.

We are also pleased to announce the appointment of Kyran McLaughlin as Senior Independent Director of Ryanair.

I very much look forward to working with both Emer and Kyran to continue to grow Ryanair safely and profitably in the best interests of our customers, our people and our shareholders.”

For more information : http://www.ryanair.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.